Explore answers to our most commonly asked questions about CBD, our products, and more.
KPV is a short tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone. Unlike full melanocortin peptides, it is mainly discussed in the literature for anti-inflammatory and epithelial-barrier-related research. On a site page, it should be framed as a research peptide for inflammation and barrier-biology studies.
Researchers most often study KPV in models involving inflammatory signaling, intestinal or epithelial barrier function, and epithelial matrix-related immune response. The accurate wording is that it is investigated for those pathways in preclinical systems, not that it is an established treatment for inflammatory disease.
Subscribe to receive your promo code and occasional email updates about new research materials.
By subscribing, you agree to our Privacy and Cookie Policy and Terms & Conditions.
Our agents are here to help you.
The products on this website are for legitimate research use only. They are not intended to prevent, treat, or cure any illness or disease and are not intended for human consumption. By accessing this site, you acknowledge that you are at least 21 years of age, understand these terms, and have a legitimate research basis for buying these products.
NOTE: All of our compounds are sold individually and are supplied as research materials only. Laboratory consumables are not included, and we do not provide reconstitution, administration, or human-use instructions.
